AA
DMII

ABC Arbitrage’s Drugs Made In America Acquisition II Corp DMII Stock Holding History

ABC Arbitrage’s Portfolio DMII Stock Details DMII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$352K Sell
35,000
-5,000
-13% -$50.2K 0.04% 172
2026
Q1 		$399K Hold
40,000
– – 0.05% 140
2025
Q4 		$396K Buy
+40,000
New +$395K 0.04% 180

Other funds holding DMII

CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
MCS
Mercuria Capital Strategies Houston, Texas $163M AUM 258.7% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System Harrisburg, Pennsylvania $20.6B AUM 37.37% 1-Year Est. Return
DAM
Deltec Asset Management New York $677M AUM 31.67% 1-Year Est. Return
TCM
Tuttle Capital Management Riverside, Connecticut $148M AUM 64.07% 1-Year Est. Return

ABC Arbitrage's DMII Position: Q2 2026 in Review

ABC Arbitrage reduced its Drugs Made In America Acquisition II Corp (DMII) stake by 13% in Q2 2026, selling an estimated $50.2K and leaving 35,000 shares worth $352K. The position accounts for 0.04% of the portfolio, ranked #172.

ABC Arbitrage first reported a position in DMII in Q4 2025 and has held it in 3 quarters since. The position peaked at $399K in Q1 2026. 7 funds tracked by Wall St. Rank hold DMII as of Q2 2026.

  • ABC Arbitrage held 35,000 shares of Drugs Made In America Acquisition II Corp worth $352K as of Q2 2026.
  • ABC Arbitrage sold 5,000 Drugs Made In America Acquisition II Corp shares in Q2 2026, an estimated $50.2K.
  • Drugs Made In America Acquisition II Corp made up 0.04% of ABC Arbitrage's portfolio in Q2 2026, its #172 holding.
  • ABC Arbitrage first reported a position in Drugs Made In America Acquisition II Corp in Q4 2025 and has held it in 3 quarters since.
  • ABC Arbitrage's Drugs Made In America Acquisition II Corp position peaked at $399K in Q1 2026.
  • 7 funds tracked by Wall St. Rank held Drugs Made In America Acquisition II Corp as of Q2 2026.

Based on ABC Arbitrage's 13F filing for Q2 2026, filed 20 Jul 2026.